Every public payer negotiation ends the same way. Weeks of deadline coverage, dueling statements, patients caught in the middle — then the joint announcement: a multi-year agreement that restores in-network access. The contracting team did its job. The rates are better. Everyone exhales.
That exhale is the most expensive moment of the entire dispute. Because the negotiation that mattered most wasn't the one that just closed. It was the quieter one running in parallel — the one the health system wasn't in.
The other negotiation
While the public fight ran, every self-funded employer with covered lives in that network was having a different conversation. Their broker called. Their consultant brought options. The question on the table wasn't who's right — it was how do we make sure our people and our budget are never held hostage to one of these again.
The answers have matured into a product shelf. A musculoskeletal carveout routing surgical volume to a bundled national provider. A center-of-excellence program for oncology or cardiac care. A navigation layer, a second-opinion vendor, a direct arrangement with another system. Roughly a quarter of large employers now run a standalone musculoskeletal program. Among the largest purchasers, two-thirds steer volume through centers of excellence and nearly half redirect site of care. Full direct contracts are still the leading edge — but the carveout layer is the mainstream. And a public dispute is precisely the event that moves one of these from a consultant's deck to a funded line item at the next renewal.
The lesson that doesn't reverse
For decades, the relationship between health systems and employers had a forgiving shape. Employers needed payors to reach the systems they wanted — the network was the access, and buying benefits mostly meant choosing whose network to rent. So when a system and a payor went to war, employers grumbled, sometimes advocated, and ultimately did what the payor told them they had to. The only real exit was switching carriers: enormous, disruptive to their own employees, almost never used. Systems learned — correctly, at the time — that volume snapped back after a settlement, because there was nowhere else for it to live.
What changed isn't employer patience. It's what employers know. The payor is no longer the only route to care, and every public negotiation teaches that lesson to another cohort of benefits committees: the intermediaries are optional, the workarounds are real, and someone is selling one. Individual programs come and go — plenty of point solutions get dropped for thin uptake, vendors get swapped at renewal. What never comes back is the old belief that a negotiation between two entities who may not know your company's name is simply weather to be endured. An employer who has carved out once, or watched a peer do it, doesn't return to that mentality when the contract signs. There is nothing to reverse, because nothing was signed. The lesson compounds instead — and in markets where the same system has gone public three or four times since 2020, it has been taught three or four times.
Where it lands
Not evenly. Carveouts and steerage concentrate where the economics justify a vendor's fee: high-cost, shoppable, schedulable care. Musculoskeletal. Surgical. Increasingly oncology. The same service lines whose rates just got fought for hardest — because both sides of this market read the same margin data.
So the post-settlement ledger looks like this: better rates, applied to a book quietly thinner exactly where it was supposed to be thickest. The contracting scoreboard says win, and on its own terms it's right. Eighteen months later, finance is looking at net revenue in those service lines and asking a question that no single function is positioned to answer.
"But we're still the better option"
The most common response inside systems: employers understand the dynamics — even after a hard negotiation, we're the higher-quality, often lower-cost option locally. Frequently true. Also answering the wrong comparison. A carveout doesn't weigh one local system against another; it weighs a service line against a bundled national rate, fixed and warrantied, at a facility chosen for exactly this purpose. And the person deciding isn't rendering a judgment about the system at all. Benefits committees don't do gratitude or grievance — they set defaults. Once the default routes elsewhere, local superiority never gets a vote, because the plan was designed so it wouldn't.
No one's job — which is the point
None of this reflects failure inside the system. Managed care, strategy, finance, and marketing are each protecting commercial revenue with the instruments their function owns — and doing it well. The loss lives in the seams: it occurs after the contract closes, in territory no mandate covers, which means even excellent teams with the best intentions have no natural reason to be looking. Historically, there was also little reason to build the capacity. When payors controlled access, long-term employer relationships were goodwill without infrastructure — and across the negotiations I've worked on, the same discovery repeats: when a system finally wants to bring employers into the picture, it finds it can't yet say which employers drive its commercial volume, how they fund their plans, or who advises them. That map was never needed before. It is now — because the relationships it describes have become the one part of the commercial equation that can't be replaced. Every negotiation proves that health plans, and even health systems, are substitutable. The employers funding the commercial volume are not.
The meeting already on someone's calendar
The press release says the relationship is restored. It isn't — it's unexamined. Somewhere in your market, a benefits committee that stood something up during the last dispute is meeting this quarter to decide whether to expand it. They're not angry. They're not thinking about you at all.
What's your plan for that meeting?
← All insights